公开(公告)号：EP3261622A1

公开(公告)日：2018-01-03

申请号：EP16756086.1

申请日：2016-02-19

申请人： Omthera Pharmaceuticals Inc.

发明人： KUBOTA, Hironori ,  ROGEAU, Etienne Thierry Charles ,  AMEMIYA, Toru ,  MEISSONNIER, Julien Georges ,  HOLMÉN, Anders Gillis ,  RADEVIK, Andreas ,  CARLSSON, Hans ,  SCHANTZ, Bengt Staffan

IPC分类号： A61K9/14

CPC分类号： A61K9/4891 ,  A61K9/4808 ,  A61K9/4825 ,  A61K9/4833 ,  A61K9/5026 ,  A61K9/5047 ,  A61K9/5057 ,  A61K31/135 ,  A61K31/202 ,  A61K2300/00 ,  A61P1/16 ,  A61P3/06 ,  A61P11/00

摘要： Capsular dosage forms containing polyunsaturated fatty acid (PUFA) compositions are provided herein. In certain embodiments, unit dosage forms comprising a plurality of millicapsules containing a PUFA composition therein are provided as well as their methods of use and manufacture. In certain embodiments, capsular dosage forms are provided herein that include a unit dosage form comprising a plurality of millicapsules containing a polyunsaturated free fatty acid substantially in free acid form. In some embodiments, the PUFA composition is Epanova®.